319 results on '"Martinez-Climent, Jose A."'
Search Results
2. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma
3. Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis
4. Activation of the PP2A-B56α heterocomplex synergizes with venetoclax therapies in AML through BCL2 and MCL1 modulation
5. Chronic docosahexaenoic acid supplementation improves metabolic plasticity in subcutaneous adipose tissue of aged obese female mice
6. The alternative RelB NF-κB subunit is a novel critical player in diffuse large B-cell lymphoma
7. Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma
8. Deep MRD profiling defines outcome and unveils different modes of treatment resistance in standard- and high-risk myeloma
9. CLL intraclonal fractions exhibit established and recently acquired patterns of DNA methylation
10. B-cell leukemia transdifferentiation to macrophage involves reconfiguration of DNA methylation for long-range regulation
11. Abstract 5117: Combined treatment with the epigenetic drug CM272 and an anti-BCL-XL proapoptotic drug sensitizes solid tumors to immune checkpoint blockade
12. Supplementary Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
13. Supplementary Figures S1-S7 from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
14. Data from Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
15. Supplementary Tables 1-6 from Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer
16. Supplementary Figures 1-2 from Deletion of Chromosome 11q Predicts Response to Anthracycline-Based Chemotherapy in Early Breast Cancer
17. Large T cell clones expressing immune checkpoints increase during multiple myeloma evolution and predict treatment resistance
18. Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
19. DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
20. Immune Biomarkers of Survival and Severe Infection in Newly Diagnosed Multiple Myeloma (NDMM) Patients (pts) Treated with the Backbone Regimen Lenalidomide and Dexamethasone (Rd)
21. OAB-033: Pre-clinical models of genetically heterogeneous multiple myeloma reveal mechanisms of immune escape and predict clinical immunotherapy outcomes
22. Downregulation of FOXP1 is required during germinal center B-cell function
23. MALT1 Small Molecule Inhibitors Specifically Suppress ABC-DLBCL In Vitro and In Vivo
24. Expression of MALT1 oncogene in hematopoietic stem/progenitor cells recapitulates the pathogenesis of human lymphoma in mice
25. Identification of LMO2 transcriptome and interactome in diffuse large B-cell lymphoma
26. A cyclin-D1 interaction with BAX underlies its oncogenic role and potential as a therapeutic target in mantle cell lymphoma
27. Preneoplastic somatic mutations including MYD88L²⁶⁵P in lymphoplasmacytic lymphoma
28. Do long lived seabirds reduce the negative effects of acute pollution on adult survival by skipping breeding? A study with European storm petrels (Hydrobates pelagicus) during the “Prestige” oil-spill
29. Spacing pattern, intersexual competition and niche segregation in American mink
30. Preneoplastic somatic mutations including MYD88 L265P in lymphoplasmacytic lymphoma
31. Reversion of epigenetically mediated BIM silencing overcomes chemoresistance in Burkitt lymphoma
32. Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
33. Lymphoma-Derived IL-10 Is a Key Immunomodulatory Factor at the Tumor Microenvironment of Activated B-Cell Diffuse Large B-Cell Lymphoma and Influences In Vivo Responses to Immunotherapy
34. Comprehensive Characterization of the Bone Marrow Microenvironment Transcriptional Remodeling in the Progression from MGUS to Smoldering and Multiple Myeloma
35. Remodeling of the Immune Microenvironment By Oncogenic MYD88 Dictates Immunotherapy Responses across Indolent and Aggressive B-Cell Lymphomas
36. Genomic Profiling of Mantle Cell Lymphoma
37. Endogenous Retroelement Activation by Epigenetic Therapy Reverses the Warburg Effect and Elicits Mitochondrial-Mediated Cancer Cell Death
38. LITAF, a BCL6 target gene, regulates autophagy in mature B-cell lymphomas
39. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma
40. Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells
41. Discordances between Immunofixation (IFx) and Minimal Residual Disease (MRD) Assessment with Next-Generation Flow (NGF) and Sequencing (NGS) in Patients (Pts) with Multiple Myeloma (MM): Clinical and Pathogenic Significance
42. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes
43. GeneChip analyses point to novel pathogenetic mechanisms in mantle cell lymphoma
44. Scale for assessing quality of life of children survivors of cranial posterior fossa tumors
45. Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia
46. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes
47. Molecular heterogeneity in MCL defined by the use of specificVH genes and the frequency of somatic mutations
48. Transformation of follicular lymphoma to diffuse large cell lymphoma is associated with a heterogeneous set of DNA copy number and gene expression alterations
49. The Pathogenesis of Multiple Myeloma (MM) Is Preceded By Mutated Lymphopoiesis and B Cell Oligoclonality That Persist in Patients with Negative Minimal Residual Disease (MRD)
50. Waldenström's Macroglobulinemia (WM) Is Preceded By Clonal Lymphopoiesis Including MYD88 L265P in Progenitor B Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.